PortfoliosLab logoPortfoliosLab logo
ISIN
BMG4690M1010
CUSIP
G4690M101
IPO Date
Aug 7, 2020

Highlights

Market Cap
$442.02M
Enterprise Value
$503.05M
EPS (TTM)
$3.21
PE Ratio
9.19
PEG Ratio
0.05
Total Revenue (TTM)
$626.95M
Gross Profit (TTM)
$133.71M
EBITDA (TTM)
$70.34M
Year Range
$25.94 - $42.99
Target Price
$24.00
ROA (TTM)
15.87%
ROE (TTM)
29.34%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

IBEX Performance Chart

IBEX Limited (IBEX) is down 22.8% since the beginning of the year. At $29 per share, IBEX is trading 31.4% below its 52-week high of $43. Investors who bought $1,000 worth of IBEX shares 5 years ago would now be looking at an investment worth $1,560.


Loading charts...

S&P 500 Index

Returns By Period

IBEX Limited (IBEX) has returned -22.79% so far this year and 7.28% over the past 12 months.


IBEX Limited

1D
-2.45%
1M
-7.93%
YTD
-22.79%
6M
-23.88%
1Y
7.28%
3Y*
12.15%
5Y*
9.30%
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBEX Monthly Returns History

Based on dividend-adjusted daily data since Aug 7, 2020, IBEX's average daily return is +0.09%, while the average monthly return is +1.34%. At this rate, an investment would double in approximately 4.3 years.

Historically, 49% of months were positive and 51% were negative. The best month was Sep 2025 with a return of +37.2%, while the worst month was Feb 2026 at -22.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, IBEX closed higher 51% of trading days. The best single day was Sep 12, 2025 with a return of +36.5%, while the worst single day was Sep 14, 2023 at -25.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-2.57%-22.31%-7.20%3.47%14.02%-6.83%-22.79%
20252.42%14.99%-3.79%2.83%14.98%1.08%1.62%-0.14%37.22%-7.77%-5.83%8.50%77.66%
2024-5.21%-11.43%-3.32%-15.10%19.47%3.39%7.79%-1.15%15.89%-10.11%14.14%4.83%13.05%
20237.40%4.72%-12.70%-16.11%0.05%3.66%-6.50%-1.46%-21.01%5.63%8.64%7.22%-23.50%
202212.65%8.61%1.08%-2.82%15.56%-5.75%7.05%-6.59%10.08%3.55%34.22%-3.72%92.79%
2021-1.50%19.49%-0.05%5.00%-5.89%-10.21%5.69%-12.85%-5.45%-4.41%-18.62%-2.53%-31.07%

Benchmark Metrics

IBEX Limited has an annualized alpha of 12.71%, beta of 0.68, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since August 07, 2020.

  • This stock participated in 85.70% of S&P 500 Index downside but only 68.24% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.68 may look defensive, but with R2 of 0.05 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
12.71%
Beta
0.68
0.05
Upside Capture
68.24%
Downside Capture
85.70%

Return for Risk

Risk / Return Rank

IBEX ranks 48 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


IBEX Risk / Return Rank: 4848
Overall Rank
IBEX Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
IBEX Sortino Ratio Rank: 4949
Sortino Ratio Rank
IBEX Omega Ratio Rank: 4848
Omega Ratio Rank
IBEX Calmar Ratio Rank: 4747
Calmar Ratio Rank
IBEX Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for IBEX Limited (IBEX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IBEXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.89

Sortino ratioReturn per unit of downside risk

-2.03

Omega ratioGain probability vs. loss probability

1.09

1.37

-0.28

Calmar ratioReturn relative to maximum drawdown

0.20

2.78

-2.59

Martin ratioReturn relative to average drawdown

0.37

12.44

-12.07

Dividends

Dividend History


IBEX Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the IBEX Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the IBEX Limited was 56.04%, occurring on Apr 17, 2024. Recovery took 266 trading sessions.

The current IBEX Limited drawdown is 29.81%.


Related event

Drawdown

Fall

Recovery

Underwater

2024 bear market2024
-56.04%Apr 2024
1y 1mo1y 22d
2y 2moFeb 2023 - May 2025
2021 bear market2021
-51.90%Dec 2021
7mo 17d11mo 24d
1y 7moApr 2021 - Nov 2022
2020 bear market2020
-48.50%Sep 2020
1mo 11d2mo 2d
3mo 13dAug 2020 - Nov 2020
2026 bear market2026
-37.14%Mar 2026
6mo 9d
9mo 7dSep 2025 - now
2021 correction2021
-19.18%Jan 2021
26d1mo 16d
2mo 12dDec 2020 - Feb 2021

Drawdown Indicators


IBEXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-56.04%

-56.78%

+0.74%

Max Drawdown (1Y)

Largest decline over 1 year

-37.14%

-9.10%

-28.04%

Max Drawdown (3Y)

Largest decline over 3 years

-39.17%

-18.90%

-20.27%

Max Drawdown (5Y)

Largest decline over 5 years

-56.04%

-25.43%

-30.61%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-29.81%

-1.80%

-28.01%

Average Drawdown

Average peak-to-trough decline

-25.59%

-10.71%

-14.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.73%

2.03%

+17.70%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of IBEX Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how IBEX Limited is priced in the market compared to other companies in the Information Technology Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for IBEX, comparing it with other companies in the Information Technology Services industry. Currently, IBEX has a P/E ratio of 9.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for IBEX compared to other companies in the Information Technology Services industry. IBEX currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for IBEX relative to other companies in the Information Technology Services industry. Currently, IBEX has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for IBEX in comparison with other companies in the Information Technology Services industry. Currently, IBEX has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with IBEX

Add IBEX Limited to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with IBEX